Hims & Hers Health, Inc.
HIMSNew York Stock ExchangeFull coverage
Price
Loading your watchlists
Cash flow statement
For a spreadsheet set to a decimal comma. Applies to Copy table and Download CSV.
USD millions
| Line | Trend | FY 2025Ended Dec 31, | FY 2024Ended Dec 31, | FY 2023Ended Dec 31, | FY 2022Ended Dec 31, | FY 2021Ended Dec 31, | FY 2020Ended Dec 31, | FY 2019Ended Dec 31, |
|---|---|---|---|---|---|---|---|---|
| Net income | ||||||||
| Depreciation and amortization | ||||||||
| Amortization of intangible assets | ||||||||
| Stock-based compensation | ||||||||
| Deferred income taxes | ||||||||
| Change in inventories | ||||||||
| Change in payables and accrued liabilities | ||||||||
| Change in payables | ||||||||
| Cash from operating activities | ||||||||
| Purchases of productive assets | ||||||||
| Acquisitions, net of cash acquired | ||||||||
| Purchases of investments | ||||||||
| Purchases of available-for-sale debt securities | ||||||||
| Sales and maturities of investments | ||||||||
| Sales of available-for-sale debt securities | ||||||||
| Maturities of available-for-sale securities | ||||||||
| Cash from investing activities | ||||||||
| Debt issued | ||||||||
| Long-term debt issued | ||||||||
| Debt repaid | ||||||||
| Long-term debt repaid | ||||||||
| Share repurchases | ||||||||
| Cash from financing activities | ||||||||
| Effect of exchange rates on cash | ||||||||
| Net change in cash | ||||||||
| Cash at end of period | ||||||||
| Interest paid | ||||||||
| Income taxes paid | ||||||||
| Operating lease payments | ||||||||
| Right-of-use assets obtained for new operating leases | ||||||||
Use the arrow keys to move between values, and Enter to see where a value comes from.
Growth
| Line | Q3 2026vs a year earlier | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Revenue | ||||
| Gross profit | ||||
| Diluted EPS | ||||
| Diluted share count |
Margins
| Margin | TTM Q4 2021Ended Dec 31, | TTM Q1 2022Ended Mar 31, | TTM Q2 2022Ended Jun 30, | TTM Q3 2022Ended Sep 30, | TTM Q4 2022Ended Dec 31, | TTM Q1 2023Ended Mar 31, | TTM Q2 2023Ended Jun 30, | TTM Q3 2023Ended Sep 30, | TTM Q4 2023Ended Dec 31, | TTM Q1 2024Ended Mar 31, | TTM Q2 2024Ended Jun 30, | TTM Q3 2024Ended Sep 30, | TTM Q4 2024Ended Dec 31, | TTM Q1 2025Ended Mar 31, | TTM Q2 2025Ended Jun 30, | TTM Q3 2025Ended Sep 30, | TTM Q4 2025Ended Dec 31, | TTM Q1 2026Ended Mar 31, | TTM Q2 2026Ended Jun 30, | TTM Q3 2026Ended Sep 30, |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | ||||||||||||||||||||
| Operating margin | ||||||||||||||||||||
| Net margin | ||||||||||||||||||||
| EBITDA margin |